Organigram Global Inc. (TSX:OGI)
Canada · Delayed Price · Currency is CAD | Market Cap | 208.14M -1.5% |
| Revenue (ttm) | 274.19M +41.3% |
| Net Income | -25.21M |
| EPS | -0.19 |
| Shares Out | 140.64M |
| PE Ratio | n/a |
| Forward PE | 16.76 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 322,395 |
| Average Volume | 245,280 |
| Open | 1.530 |
| Previous Close | 1.500 |
| Day's Range | 1.460 - 1.530 |
| 52-Week Range | 1.460 - 3.090 |
| Beta | 1.91 |
| RSI | 25.71 |
| Earnings Date | May 12, 2026 |
About Organigram Global
Organigram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including cannabis flowers, cannabis oils, and vaporizers for civilian patients and veterans; adult use recreational cannabis under the Edison Cannabis Co., Trail Blazer, SHRED, SHRED'ems, Big Bag O' Buds, and Monjour brands; and cannabis edibles products and concentrates. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and c... [Read more]
Full Company ProfileFinancial Performance
In fiscal year 2025, Organigram Global's revenue was 259.18 million, an increase of 62.15% compared to the previous year's 159.84 million. Losses were -24.76 million, -45.51% less than in 2024.
Financial StatementsNews
Organigram Global Inc (OGI) Q2 2026 Earnings Call Highlights: Navigating Challenges and Seizing ...
Organigram Global Inc (OGI) Q2 2026 Earnings Call Highlights: Navigating Challenges and Seizing Growth Opportunities
Organigram Global Earnings Call Transcript: Q2 2026
Q2 fiscal 2026 saw revenue and margin declines due to operational issues and market softness, but remediation efforts and the Sanity Group acquisition are expected to drive stronger performance in the second half. Guidance for fiscal 2026 projects net revenue above CAD 350 million and improved profitability.
OGI Reports Q2 Financials with Adjusted EBITDA Decline
OGI Reports Q2 Financials with Adjusted EBITDA Decline
OGI Forecasts Strong FY26 Adjusted EBITDA and Low Capital Expenditures
OGI Forecasts Strong FY26 Adjusted EBITDA and Low Capital Expenditures
Options Volatility and Implied Earnings Moves Today, May 12, 2026
Today, several major companies are expected to report earnings: Lineage Therap (LCTX), Achieve Life Sciences (ACHV), Zebra Tech (ZBRA), Organigram Global (OGI), Lithium Argentina (LAR), GrowGeneration...
Organigram Reports Second Quarter Fiscal 2026 Results
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 cannabis company by market share1, is pleased to announce its results for the se...
Organigram (OGI) Set to Release Q2 FY2026 Earnings Report
Organigram (OGI) Set to Release Q2 FY2026 Earnings Report
Organigram to Report Second Quarter Fiscal 2026 Results on May 12th, 2026
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 cannabis company by market share, announced today it will report earnings result...
Organigram (OGI) Completes Acquisition of Sanity Group
Organigram (OGI) Completes Acquisition of Sanity Group
Organigram closes acquisition of Sanity Group
Organigram (OGI) Global and Sanity Group jointly announced the successful closing of Organigram’s previously announced acquisition of Sanity Group, pursuant to the terms of a share purchase agreement ...
Organigram Closes Previously Announced Acquisition of Sanity Group, Private Placement Financing with BAT and ATB Senior Secured Credit Facilities
TORONTO & BERLIN--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”) and Sanity Group GmbH (“Sanity” or “Sanity Group”) jointly announced the successful ...
Organigram Announces Shareholder Approval of Acquisition of Sanity Group GmbH and Results of its Annual General and Special Meeting
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), is pleased to announce that the shareholders of Organigram have overwhelmingly approved the ...
Organigram (OGI) Gains Support for Sanity Group Acquisition
Organigram (OGI) Gains Support for Sanity Group Acquisition
ISS urges Organigram shareholders to vote for Sanity Group acquisition
Organigram (OGI) is pleased to announce that Institutional Shareholder Services has recommended that holders of common shares of Organigram vote FOR the ordinary resolution to approve the indirect acq...
Organigram Announces Independent Proxy Advisory Firm ISS Recommends Organigram Shareholders Vote FOR the Acquisition of Sanity Group GmbH
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce that Institutional Sharehold...
Organigram Announces Mailing of Management Information Circular in Connection with Annual General and Special Meeting
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today that it has mailed and filed a mana...
Organigram Global Expands FAST™ Innovation Platform with SHRED Shotz, Leveraging SHRED Brand Equity
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 cannabis company by market share1 is pleased to announce the launch of SHRED Sho...
3 Canadian Marijuana Stocks To Diversify Your Stock Portfolio
Marijuana stocks, even with their volatile behavior, still offer diverse investment opportunities. Not every sector or company deals directly with the plant, so investors see this as an opportunity to...
Organigram (OGI) Expands Product Line in Australia with New Launch
Organigram (OGI) Expands Product Line in Australia with New Launch
Organigram launches Edison and BOXHOT products in Australia
Organigram (OGI) Global announced the expansion of its international product portfolio, with the launch of Edison and BOXHOT medical cannabis vape and pastille products in Australia. Organigram alread...
Organigram Further Expands Global Portfolio with Launch of Edison and BOXHOT Medical Vapes and Pastilles in Australia
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (“Organigram” or the “Company”) today announced the expansion of its international product portfolio, with the launch of Edison and BOXHOT medical cann...
Organigram price target raised to C$4 from C$3 at Canaccord
Canaccord raised the firm’s price target on Organigram (OGI) to C$4 from C$3 and keeps a Buy rating on the shares.
What's Going On With Organigram Global Stock Thursday?
Organigram Global Inc. (OGI) shares rose after a $65.2 million private placement investment from British American Tobacco's subsidiary. ... Full story available on Benzinga.com
Organigram (OGI) Gains on C$65.2M Investment from British American Tobacco
Organigram (OGI) Gains on C$65.2M Investment from British American Tobacco
Organigram announces C$65.2M BAT private placement investment
Organigram Global (OGI) announced that it has entered into a subscription agreement with BT DE Investments, a wholly-owned subsidiary of British American Tobacco (BTI), in connection with its previous...